BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the prestigious Precision Medicine World Conference (PMWC) in Silicon Valley.

Long read sequencing revealed more genetic information in cases of 42 patients with rare diseases while cutting time and cost of diagnoses.

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

Comment from Associate Professor Jun Takayama, Tohoku University School of Medicine "The accuracy validation using the RASEN ...

The New York architect facing murder charges in a string of deaths known as the Gilgo Beach killings on Long Island is ...

CHENNAI: IIT Madras on Monday launched the Bharat Cancer Genome Atlas (BCGA) with data on 960 whole exome sequencing it has ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

DNA Sequencing Market Fueled by Genomics Research, Personalized Medicine, and AI-Powered Advancements, the DNA Sequencing <a target=_blank ...

Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of ...

Chennai: Ahead of World Cancer Day, The Indian Institute of Technology (IIT) Madras on Monday launched Bharat cancer genome ...

The Research was led by the Institute's Centre of Excellence on Cancer Genomics and Molecular Therapeutics, which was funded ...